Improving the estimation of tuberculosis infection prevalence using T-cell-based assay and mixture models

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 8, 2008, Pages 895-902

  Pai, Madhukar ^a,b   Dendukuri, N ^a,c   Wang, L ^d   Joshi, R ^e   Kalantri, S ^e   Rieder, H L ^f  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES   (India)

^f INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

Author keywords

Interferon gamma release assay; Latent class analysis; Mixture model; Prevalence; Tuberculin skin test; Tuberculosis

Indexed keywords

ADULT; ARTICLE; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; TUBERCULIN TEST; TUBERCULOSIS;

BAYES THEOREM; HUMANS; INTERFERON-GAMMA; MODELS, THEORETICAL; PREVALENCE; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; TUBERCULIN TEST; TUBERCULOSIS;

EID: 49149087071     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione M C. Consensus Statement. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282: 677-686.
2. Joshi R, Reingold A L, Menzies D, Pai M. Tuberculosis among health care workers in low- and middle-income countries: a systematic review. PLoS Med 2006; 3: e494.
3. Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 2007; 11: 593-605.
4. Arnadottir T, Rieder H L, Trebucq A, Waaler H T. Guidelines for conducting tuberculin skin test surveys in high prevalence countries. Tubercle Lung Dis 1996; 77 (Suppl 1): 1-19.
5. Dye C, Bassili A, Bierrenbach A, et al. Measuring tuberculosis burden, trends, and the impact of control programmes. Lancet Infect Dis 2008; 8: 233-243.
6. Menzies R I. Tuberculin skin testing. In: Reichman L B, Hershfield E S, eds. Tuberculosis: a comprehensive international approach. New York, NY, USA: Marcel Dekker, 2000: pp 279-322.
7. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006; 10: 1192-1204.
8. Pai M, Riley L W, Colford J M Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4: 761-776.
9. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: Part 1. Latent tuberculosis. Expert Rev Mol Diagn 2006; 6: 413-422.
10. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-354.
11. Pai M, Kalantri S, Menzies D. Discordance between tuberculin skin test and interferon-gamma assays. Int J Tuberc Lung Dis 2006; 10: 942-943.
12. Pai M, Dheda K, Cunningham J, Scano F, O'Brien R. T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis 2007; 7: 428-438.
13. Deck F, Guld J. The WHO tuberculin test. Bull Int Union Tuberc 1964; 34 (1): 53-70.
14. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161 (Suppl): S221-S247.
15. Neuenschwander B E, Zwahlen M, Kim S J, Engel R R, Rieder H L. Trends in the prevalence of infection with Mycobacterium tuberculosis in Korea from 1965 to 1995: an analysis of seven surveys by mixture models. Int J Tuberc Lung Dis 2000; 4: 719-729.
16. Neuenschwander B E, Zwahlen M, Kim S J, Lee E G, Rieder H L. Determination of the prevalence of infection with Mycobacterium tuberculosis among persons vaccinated with bacillus Calmette-Guerin in South Korea. Am J Epidemiol 2002; 155: 654-663.
17. Trebucq A, Guerin N, Ali Ismael H, Bernatas J J, Sevre J P, Rieder H L. Prevalence and trends of infection with Mycobacterium tuberculosis in Djibouti, testing an alternative method. Int J Tuberc Lung Dis 2005; 9: 1097-1104.
18. Hadgu A, Dendukuri N, Hilden J. Evaluation of nucleic acid amplification tests in the absence of a perfect gold-standard test: a review of the statistical and epidemiologic issues. Epidemiology 2005; 16: 604-612.
19. Scott A N, Joseph L, Belisle P, Behr M A, Schwartzman K. Bayesian modelling of tuberculosis clustering from DNA fingerprint data. Stat Med 2008; 27: 140-156.
20. Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood, interferon-γ assay with tuberculin skin testing. JAMA 2005; 293: 2746-2755.
21. Chadha V K, Jagannatha P S, Vaidyanathan P S, Jagota P. PPD RT23 for tuberculin surveys in India. Int J Tuberc Lung Dis 2003; 7: 172-179.
22. Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004; 170: 59-64.
23. Mazurek G H, Jereb J, Lobue P, Iademarco M F, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54: 49-55.
24. Neuenschwander B E. Bayesian mixture analysis for tuberculin induration data. Paris, France: International Union Against Tuberculosis and Lung Disease, 2007. http://www.tbrieder.org Accessed May 2008.
25. Goodman S N. Toward evidence-based medical statistics. 2: The Bayes factor. Ann Intern Med 1999; 130: 1005-1013.
26. Goodman S N. Introduction to Bayesian methods. I: measuring the strength of evidence. Clin Trials 2005; 2: 282-290; discussion 301-304, 64-78.
27. Joseph L, Gyorkos T W, Coupal L. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard. Am J Epidemiol 1995; 141: 263-272.
28. Dendukuri N. WinBUGS programs for modeling results of two conditionally dependent, non-gold standard diagnostic tests using latent class analysis. Montreal, Canada: McGill University, 2007. http://www.medicine.mcgill.ca/ epidemiology/ dendukuri/stat%20software.htm Accessed May 2008.
29. Rieder H. Annual risk of infection with Mycobacterium tuberculosis. Eur Respir J 2005; 25: 181-185.
30. Rieder H L. Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys. Tubercle Lung Dis 1995; 76: 114-121.
31. World Health Organization. Generic guidelines for the estimation of the annual risk of tuberculosis infection. New Delhi, India: WHO, SEARO, 2006.
32. Dendukuri N, Hadgu A, Wang L. Modeling conditional dependence between diagnostic tests due to multiple latent variables: a hierarchical latent class model. In: Proceedings of the Joint Statistical Meetings of the American Statistical Association, 2005. Minneapolis, MN, USA: ASA, 2005.
33. Hadgu A, Qu Y. A biomedical application of latent class models with random effects. Applied Statistics 1998; 47: 603-616.